glycerophosphoinositol 4,5-bisphosphate has been researched along with Friedreich Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubry, L; Bayot, A; Csaba, Z; Husson, I; Lebon, S; Rak, M; Reichman, S; Rustin, P; Sterkers, G | 1 |
1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Friedreich Disease
Article | Year |
---|---|
Cis-silencing of PIP5K1B evidenced in Friedreich's ataxia patient cells results in cytoskeleton anomalies.
Topics: Cytoskeleton; Fibroblasts; Frataxin; Friedreich Ataxia; Gene Silencing; Humans; Iron-Binding Proteins; Lymphocytes; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphotransferases (Alcohol Group Acceptor); Trinucleotide Repeat Expansion | 2013 |